Bavarian Nordic A/S (BAVA) announced on November 15, that its subsidiary, BN ImmunoTherapeutics has started the pivotal Phase 3 trial of PROSTVAC® for men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. The trial is being conducted under a Special Protocol Assessment agreement with the FDA. Notice this trial has the same criteria as [...]
If you want to call me an advocate, say that I am a black (and brown!) male health and fatherhood advocate. Say I created BDC because disparities in African American health exist. Say I blog because injustice is still here (and in every paycheck Snooki receives). I do this work because I love this country [...]
I know I'm late! I'm just keeping it real and keeping it busy. And keeping it real busy. I have a new post about injustice (some light reading) up at my other non-profit blog. Please support and link and all that other stuff! Click here to read.
On the eve of what would have been Dr. King's 83rd birthday, I sit in reflection, an amalgamation of both frustration and hopefulness. The frustration comes from being acutely aware that we are in the process of losing an entire generation of black males, despite who sits in the White House. There are more black [...]
According to a an article published in the January 2012 issue of Cancer Prevention Research, estrogen may play a role in Melanoma recurrences! The article described a large cohort study of women who were put on an anti-estrogen therapy. The study concluded that those women on the anti-estrogen therapy had a lower risk of melanoma. [...]
Neulasta (Pegfilgrastim) is used to reduce the chance of infection in people who have certain cancers and are also receiving chemotherapy medications, including taxotere for men being treated for advanced prostate cancer. Chemotherapy is designed to kill fast growing cells. However, it can’t tell the difference between cancer cells and fast-growing healthy cells, including red [...]
We are about to finally get a more formal presentation of the great news we have all been waiting to hear. Medivation Inc. and Astellas Pharma Inc. announced that data from their Phase 3 AFFIRM trial, evaluating MDV3100 in men with advanced prostate cancer, will be highlighted in a late-breaking oral presentation at the upcoming [...]
Considering yesterday's post about the problems with fentanyl patches today's post becomes even more scarey. The Food and Drug Administration (FDA) has made warns of opioid drug mix-up! According to the FDA pills, tablets, or caplets of Percocet and eight other opioid products packaged by Novartis for Endo Pharmaceuticals may have been mixed up, with [...]
Leslie from the Malecare Advanced Prostate Cancer On-line Support Group made a post today warning us that there have been significant malfunctions in fentanyl patches. Fentanyl patches are used to control severe pain, especially in men with very progressed advanced prostate cancer. According to the information posted some of these patches are malfunctioning causing accidental [...]
Researchers at Ohio State University report that they have developed a new mathematical model for men with advanced prostate cancer who are on androgen deprivation therapy (ADT). This model could guide future treatment decisions for men with advanced prostate cancer, specifically, helping to decide which men would benefit from ADT on an intermittent schedule (IADT). [...]
